Sanborn Kilcollin Partners’s Johnson & Johnson JNJ Stock Holding History

Sanborn Kilcollin Partners’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$8.83M	Sell	253,677 -132,159	-34%	-$13.7M	6.18%	6
2014 Q2	$11.9M	Buy	385,836 +273,237	+243%	+$27.6M	5.49%	8
2014 Q1	$11.1M	Buy	112,599 +5,383	+5%	+$499K	5.58%	8
2013 Q4	$9.82M	Sell	107,216 -6,871	-6%	-$633K	5.12%	10
2013 Q3	$9.89M	Buy	114,087 +9,373	+9%	+$841K	5.22%	10
2013 Q2	$8.99M	Buy	+104,714	New	+$8.89M	5.47%	10

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sanborn Kilcollin Partners's JNJ Position: Q3 2014 in Review

Sanborn Kilcollin Partners reduced its Johnson & Johnson (JNJ) stake by 34% in Q3 2014, selling an estimated $13.7M and leaving 253,677 shares worth $8.83M. The position accounts for 6.18% of the portfolio, ranked #6.

Sanborn Kilcollin Partners first reported a position in JNJ in Q2 2013 and has held it in 6 quarters since. The position peaked at $11.9M in Q2 2014. 1,986 funds tracked by Wall St. Rank hold JNJ as of Q3 2014.

Sanborn Kilcollin Partners held 253,677 shares of Johnson & Johnson worth $8.83M as of Q3 2014.
Sanborn Kilcollin Partners sold 132,159 Johnson & Johnson shares in Q3 2014, an estimated $13.7M.
Johnson & Johnson made up 6.18% of Sanborn Kilcollin Partners's portfolio in Q3 2014, its #6 holding.
Sanborn Kilcollin Partners first reported a position in Johnson & Johnson in Q2 2013 and has held it in 6 quarters since.
Sanborn Kilcollin Partners's Johnson & Johnson position peaked at $11.9M in Q2 2014.
1,986 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2014.

Based on Sanborn Kilcollin Partners's 13F filing for Q3 2014, filed 13 Nov 2014.